Flowers Foods Inc (NYSE:FLO) Reports Mixed Q2 2025 Results with Revenue Miss and Narrow EPS Beat

Flowers Foods Inc (NYSE:FLO) reported mixed second-quarter results for fiscal 2025, with revenue falling short of expectations while earnings per share (EPS) narrowly beat estimates. The market reaction has been negative in pre-market trading, with shares down approximately 3.6% following the release.

Key Financial Highlights

• Revenue: Reported at $1.24 billion, missing analyst estimates of $1.28 billion.
• Earnings Per Share (EPS): Came in at $0.30, slightly above the consensus estimate of $0.2987.
• Pre-Market Reaction: Shares declined ~3.6%, suggesting investor disappointment despite the EPS beat, likely due to the revenue miss.

Market Performance Context

The stock had been showing modest gains in recent weeks, with:

• A 0.02% increase over the past week.
• A 4.6% rise over the last two weeks.
• A 6.7% climb over the past month.

However, the pre-market drop indicates that the revenue shortfall is weighing more heavily on sentiment than the slight EPS beat.

Looking Ahead

Analyst estimates for the full year 2025 project:

• Revenue: $5.36 billion
• EPS: $1.12

For the upcoming third quarter, expectations are set at:

• Revenue: $1.26 billion
• EPS: $0.26

The company did not provide an explicit outlook in the press release, leaving investors to rely on analyst projections. Given the revenue miss in Q2, market participants may be reassessing growth expectations for the remainder of the year.

Press Release Summary

The earnings report confirmed Flowers Foods' continued operations across its bakery product lines, including brands like Nature’s Own, Dave’s Killer Bread, and Tastykake, distributed through supermarkets, convenience stores, and foodservice channels. While cost management helped deliver an EPS in line with expectations, top-line growth appears to be a concern.

For more detailed earnings data and future estimates, see Flowers Foods' earnings and estimates.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before making any decisions.